Pelthos Therapeutics Inc.PTHSEarnings & Financial Report
NYSE
PTHS Q3 2025 Key Financial Metrics
Revenue
$294.0K
Gross Profit
$-2.0M
Operating Profit
$-15.4M
Net Profit
$-16.2M
Gross Margin
-687.8%
Operating Margin
-5225.2%
Net Margin
-5523.1%
YoY Growth
N/A
EPS
$-5.30
Financial Flow
Pelthos Therapeutics Inc. Q3 2025 Financial Summary
Pelthos Therapeutics Inc. reported revenue of $294.0K for Q3 2025, with a net profit of $-16.2M (-5523.1% margin). Cost of goods sold was $2.3M, operating expenses totaled $13.3M.
Key Financial Metrics
| Total Revenue | $294.0K |
|---|---|
| Net Profit | $-16.2M |
| Gross Margin | -687.8% |
| Operating Margin | -5225.2% |
| Report Period | Q3 2025 |
Income Statement
| Q3 2025 | |
|---|---|
| Revenue | $294000 |
| YoY Growth | N/A |
Balance Sheet
| Q3 2025 | |
|---|---|
| Assets | $126.4M |
| Liabilities | $68.2M |
| Equity | $58.3M |
Cash Flow
| Q3 2025 | |
|---|---|
| Operating CF | $-15.3M |